Zevra Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Zevra Therapeutics, Inc. (ZVRA) reported Increase (Decrease) in Other Noncurrent Liabilities of $807.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-05
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $391.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $416.00K, a 25.71% decline year-over-year.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$5.98M, a 420.58% decline year-over-year.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $6.14M.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was -$1.16M, a 238.80% decline from fiscal 2024.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $835.00K, a 131.94% increase from fiscal 2023.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $360.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$74.00K, a 110.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $807.00K 10-Q · filed 2026-08-05 | -$5.17M derived: sum of 3 quarters · filed 2026-08-05 | $968.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $416.00K 10-Q · filed 2026-05-06 | -$5.57M derived: sum of 2 quarters · filed 2026-05-06 | $577.00K derived: sum of 3 quarters · filed 2026-05-06 | -$1.30M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | -$5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $161.00K derived: sum of 2 quarters · filed 2026-03-09 | -$1.72M derived: sum of 3 quarters · filed 2026-08-05 | -$1.16M 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $6.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.26M derived: sum of 2 quarters · filed 2026-08-05 | $4.82M 10-Q · filed 2025-11-05 | $6.69M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.32M 10-Q · filed 2026-08-05 | $1.99M 10-Q · filed 2025-08-12 | $546.00K derived: sum of 3 quarters · filed 2026-08-05 | -$817.00K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $560.00K 10-Q · filed 2026-05-06 | $2.43M derived: sum of 2 quarters · filed 2026-05-06 | $1.06M derived: sum of 3 quarters · filed 2026-05-06 | $1.69M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $503.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.13M derived: sum of 3 quarters · filed 2026-03-09 | $835.00K 10-K · filed 2026-03-09 | ||
| 2024-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$733.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.03M 10-Q · filed 2025-11-05 | -$1.39M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $630.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $332.00K 10-Q · filed 2025-08-12 | -$24.00K derived: sum of 3 quarters · filed 2025-08-12 | $70.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$298.00K 10-Q · filed 2025-05-13 | -$654.00K derived: sum of 2 quarters · filed 2025-05-13 | -$560.00K derived: sum of 3 quarters · filed 2025-05-13 | -$367.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$356.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$262.00K derived: sum of 2 quarters · filed 2025-03-12 | -$69.00K derived: sum of 3 quarters · filed 2025-03-12 | $360.00K 10-K · filed 2025-03-12 | ||
| 2023-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $287.00K derived: sum of 2 quarters · filed 2024-11-13 | $716.00K 10-Q · filed 2024-11-13 | $1.01M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $622.00K 10-Q · filed 2024-08-14 | $920.00K derived: sum of 3 quarters · filed 2024-08-14 | $887.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $429.00K 10-Q · filed 2024-05-09 | $727.00K derived: sum of 2 quarters · filed 2024-05-09 | $694.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.18M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $265.00K derived: sum of 2 quarters · filed 2024-04-01 | $747.00K derived: sum of 3 quarters · filed 2024-04-01 | -$74.00K 10-K · filed 2024-04-01 | -$371.00K 10-K · filed 2023-03-07 | |
| 2022-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $449.00K derived: sum of 2 quarters · filed 2023-11-07 | -$372.00K 10-Q · filed 2023-11-07 | -$783.00K derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$339.00K 10-Q · filed 2023-08-14 | -$750.00K derived: sum of 3 quarters · filed 2023-08-14 | -$2.11M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$821.00K 10-Q · filed 2023-05-15 | -$1.23M derived: sum of 2 quarters · filed 2023-05-15 | -$2.59M derived: sum of 3 quarters · filed 2023-05-15 | -$220.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -$411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$1.77M derived: sum of 2 quarters · filed 2023-03-07 | $601.00K derived: sum of 3 quarters · filed 2023-03-07 | $723.00K 10-K · filed 2023-03-07 | ||
| 2021-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.01M derived: sum of 2 quarters · filed 2022-11-10 | $1.13M 10-Q · filed 2022-11-10 | $1.20M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.49M 10-Q · filed 2022-08-12 | $2.56M derived: sum of 3 quarters · filed 2022-08-12 | $2.62M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $122.00K 10-Q · filed 2022-05-12 | $190.00K derived: sum of 2 quarters · filed 2022-05-12 | $250.00K derived: sum of 3 quarters · filed 2022-05-12 | $250.00K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $128.00K derived: sum of 2 quarters · filed 2022-03-31 | $128.00K derived: sum of 3 quarters · filed 2022-03-31 | $140.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $60.00K derived: sum of 2 quarters · filed 2021-11-10 | $72.00K 10-Q · filed 2021-11-10 | $62.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $12.00K 10-Q · filed 2021-08-13 | $2.00K derived: sum of 3 quarters · filed 2021-08-13 | $2.00K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $12.00K 10-Q · filed 2021-05-14 | $2.00K derived: sum of 2 quarters · filed 2021-05-14 | $2.00K derived: sum of 3 quarters · filed 2021-05-14 | -$7.00K derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$10.00K derived: sum of 2 quarters · filed 2021-03-12 | -$19.00K derived: sum of 3 quarters · filed 2021-03-12 | -$798.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$9.00K derived: sum of 2 quarters · filed 2020-10-30 | -$788.00K 10-Q · filed 2020-10-30 | -$804.00K derived: sum of 4 quarters · filed 2020-10-30 | ||
| 2019-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$788.00K 10-Q · filed 2020-08-12 | -$804.00K derived: sum of 3 quarters · filed 2020-08-12 | -$839.00K derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$779.00K 10-Q · filed 2020-05-13 | -$795.00K derived: sum of 2 quarters · filed 2020-05-13 | -$830.00K derived: sum of 3 quarters · filed 2020-05-13 | -$857.00K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$51.00K derived: sum of 2 quarters · filed 2020-02-28 | -$78.00K derived: sum of 3 quarters · filed 2020-02-28 | -$102.00K 10-K · filed 2020-02-28 | ||
| 2018-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$62.00K derived: sum of 2 quarters · filed 2019-11-14 | -$86.00K 10-Q · filed 2019-11-14 | -$110.00K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$51.00K 10-Q · filed 2019-08-13 | -$75.00K derived: sum of 3 quarters · filed 2019-08-13 | -$75.00K derived: sum of 4 quarters · filed 2019-08-13 | ||
| 2018-03-31 | -$24.00K 10-Q · filed 2019-05-14 | -$48.00K derived: sum of 2 quarters · filed 2019-05-14 | -$48.00K derived: sum of 3 quarters · filed 2019-05-14 | -$15.00K derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$24.00K derived: sum of 2 quarters · filed 2019-03-01 | $9.00K derived: sum of 3 quarters · filed 2019-03-01 | $77.00K 10-K · filed 2019-03-01 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $33.00K derived: sum of 2 quarters · filed 2018-11-09 | $101.00K 10-Q · filed 2018-11-09 | $231.00K derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $101.00K 10-Q · filed 2018-08-10 | $231.00K derived: sum of 3 quarters · filed 2018-08-10 | $253.00K derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-03-31 | $68.00K 10-Q · filed 2018-05-11 | $198.00K derived: sum of 2 quarters · filed 2018-05-11 | $220.00K derived: sum of 3 quarters · filed 2018-05-11 | $241.00K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $152.00K derived: sum of 2 quarters · filed 2018-03-30 | $173.00K derived: sum of 3 quarters · filed 2018-03-30 | $184.00K 10-K · filed 2018-03-30 | ||
| 2016-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $43.00K derived: sum of 2 quarters · filed 2017-11-09 | $54.00K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $32.00K 10-Q · filed 2017-08-10 | ||||
| 2016-03-31 | $11.00K 10-Q · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |